SGO
SGO
  • Daily Coverage
  • Photo Gallery
  • Meeting Program
  • Registration
Topics
  • Daily Coverage
  • Photo Gallery
  • Meeting Program
  • Registration
Facebook iconInstagram iconTwitter X icon LinkedIn icon
Mar 16th, 2025

Shaping the Next Generation of Leaders

The SGO LEAD 2.0 Summit, prior to the SGO 2025 Annual Meeting on Women’s Cancer, provided an opportunity for mentees to meet in person and expand their learning experience.


Lead 3

 In 2019-2020, minorities represented a mere 9% of oncology trainees, which is lower than other medical specialties. One potential reason for this small percentage is minority students are often not exposed to the oncology fields during their medical training. 

An SGO program aims to change that. The Leadership, Engagement, and Action in Diversity (LEAD) program, now in its second year, provides Underrepresented in Medicine (UriM) trainees sponsorship, resources, and a network to support their development as future gynecologic oncologists. Ahead of the SGO 2025 Annual Meeting, LEAD 2.0 participants met for the LEAD Summit featuring presentations, small groups, and panel discussions covering research development, mentorship, and more. 

Taylor Paige Stewart, MD, was among the scholars and shared that Thursday’s programming gave her the opportunity to meet her peers and mentors in person.

“I cherish face-to-face time,” said Dr. Stewart, resident in obstetrics and gynecology at Brigham & Women’s Hospital | Massachusetts General Hospital. “I look forward to further building new relationships with those I may not have spent as much time with during earlier sessions — learn from their experiences and gain insights into their lives and careers.”

The SGO LEAD program is dedicated to improving and strengthening the opportunity of URiM trainees in preparation for a successful match to gynecologic oncology fellowship, with the express goal of diversifying the field. Taylor Paige Stewart, MDTaylor Paige Stewart, MD

“As I work toward applying to gynecologic oncology fellowship this upcoming cycle, I appreciate that the (LEAD) content is relatable and translatable across all levels of training. Specifically, I can better organize and optimize my plan for research during my chief year/first year of fellowship and help lead junior residents through research,” she said. “There have been many points of this program that I wish I would have had this training and insight sooner.”

According to Dr. Stewart, the LEAD program serves as a critical example of how diversity and inclusion can be actively promoted in medical training. 

“In an era where the safeguarding of diversity across various sectors, particularly in medical education, is increasingly crucial, the LEAD program stands as a commendable model for others to emulate. By prioritizing diversity, the LEAD program not only addresses gaps in representation in training but also in diverse leadership,” she said. “As current societal climates may challenge the importance of such initiatives, the LEAD program offers a timely reminder of how purposeful, inclusive leadership can elevate excellent and intelligent individuals.” 

Interested in learning more? Contact [email protected].

Interesting Stories
Coding Corner: Intra-abdominal Tumor Excision or Destruction Code Changes
Sponsored by SGO
Coding Corner: Intra-abdominal Tumor Excision or Destruction Code Changes
Learn More About Wellness Programs
Sponsored by SGO
Learn More About Wellness Programs
View the current issue of Gynecologic Oncology
Sponsored by SGO
View the current issue of Gynecologic Oncology
More Content
Sgo Annual Meeting Saturday Photo By Fwc Awards
Home
FWC Research & Grant Recipients
Mar 17th, 2025
San Juan, Puerto Rico
Home
Save the date for SGO 2026 Annual Meeting on Women’s Cancer
Mar 17th, 2025
Karen Lu, MD
Home
Get to Know SGO’s Incoming President
Mar 17th, 2025
Sgo Annual Meeting Friday Photo By Nick Klein Awards
Home
SGO and FWC Leadership Award Winners
Mar 17th, 2025
audience shot
Home
A Potential New Detection Tool for Invasive Cervical Cancer
Mar 16th, 2025
Ginger Gardner, MD, FACOG
Home
Empowering Progress: The Foundation for Women's Cancer
Mar 16th, 2025
headshot of Dr. Choi
Daily Coverage
A Potential Second-Line Treatment for Cervical Cancer
Mar 15th, 2025
Tamar Gootzen, MD
Home
An Alternative Approach to Preventing Ovarian Cancer?
Mar 15th, 2025
Fang Jiang, MD, PhD
Home
Changing the Course for First-Line, Low-Risk Gestational Trophoblastic Neoplasia
Mar 15th, 2025
Angela Nolin, MD
Home
It’s Time to Change the Diagnosis Protocol for Endometrial Cancer
Mar 15th, 2025
Kathleen N. Moore, MD
Home
Durvalumab Plus Carboplatin and Paclitaxel Delivers One-Two Punch for Endometrial Cancer Treatment
Mar 14th, 2025
Linda Duska, MD, MPH
Home
Pembrolizumab Plus Chemotherapy Regimen Yields Clinically Positive Outcomes for Treatment of Locally Advanced Cervical Cancer
Mar 14th, 2025
SGO
Facebook iconInstagram iconTwitter X icon LinkedIn icon
© 2025 Ascend Media. All rights reserved.